Nutr Res Pract.  2015 Apr;9(2):117-122. 10.4162/nrp.2015.9.2.117.

Curcumin utilizes the anti-inflammatory response pathway to protect the intestine against bacterial invasion

• Cho JA
• Park E

• KMID: 2313818
• DOI: http://doi.org/10.4162/nrp.2015.9.2.117

Abstract

BACKGROUND/OBJECTIVES
Curcumin, a major component of the Curcuma species, contains antioxidant and anti-inflammatory properties. Although it was found to induce apoptosis in cancer cells, the functional role of curcumin as well as its molecular mechanism in anti-inflammatory response, particularly in intestinal cells, has been less investigated. The intestine epithelial barrier is the first barrier and the most important location for the substrate coming from the lumen of the gut.
SUBJECTS/METHODS
We administered curcumin treatment in the human intestinal epithelial cell lines, T84 and Caco-2. We examined endoplasmic reticulum (ER) stress response by thapsigargin, qPCR of XBP1 and BiP, electrophysiology by wild-type cholera toxin in the cells.
RESULTS
In this study, we showed that curcumin treatment reduces ER stress and thereby decreases inflammatory response in human intestinal epithelial cells. In addition, curcumin confers protection without damaging the membrane tight junction or actin skeleton change in intestine epithelial cells. Therefore, curcumin treatment protects the gut from bacterial invasion via reduction of ER stress and anti-inflammatory response in intestinal epithelial cells.
CONCLUSIONS
Taken together, our data demonstrate the important role of curcumin in protecting the intestine by modulating ER stress and inflammatory response post intoxication.

Keyword

Curcumin; Intestine; Anti-inflammatory response; NF-kappaB; Bacteria

MeSH Terms

Actins
Apoptosis
Bacteria
Cholera Toxin
Curcuma
Curcumin*
Electrophysiology
Endoplasmic Reticulum
Epithelial Cells
Humans
Intestines*
Membranes
NF-kappa B
Skeleton
Thapsigargin
Tight Junctions
Actins
Cholera Toxin
Curcumin
NF-kappa B
Thapsigargin

Figure

• 

  Fig. 1 Effect of curcumin showed reduction of ER stress in human intestinal epithelial cells. Polarized human intestinal epithelia cell lines T84 (A and B) and Caco-2 (C and D) were treated with thapsigargin apically for 4 hours following 24 hour pretreatment with different concentrations of curcumin as indicated. RNA was extracted and hallmark of ER stress, BiP mRNA level was measured by qRT-PCR. The fold change of the thapsigargin treated group was normalized by curcumin treatment only (B and D) to eliminate basal difference from each concentration of curcumin. Open bars represent negative controls. Thaps: Thapsigargin, Data are expressed as mean ± SEM. *P < 0.05 by ANOVA (A and B), t-test (C and D).

• 

  Fig. 2 Effect of curcumin on IRE1α activation in human intestinal epithelial cells. Polarized human intestinal epithelia cell lines T84 (A and B) and Caco-2 (C) were treated with thapsigargin apically for 4 hours following 24 hour pretreatment with different concentrations of curcumin as indicated. mRNA was extracted and spliced form of XBP1 mRNA level (XBP1s), downstream target gene of IRE1α, was measured by qRT-PCR. The fold change of the thapsigargin treated group was normalized by curcumin treatment only (B) to eliminate basal difference from each concentration of curcumin. Open bars represent negative controls.

• 

  Fig. 3 Effect of curcumin on the defense mechanism against bacterial invasion in human intestinal epithelial cells. Polarized human intestinal epithelia cell lines T84 (A and B) and Caco-2 (C and D) were treated with either thapsigargin for 4 hours (A) or 3 nM wild-type cholera toxin for 24 hours (B, C, and D) apically following 24 hour pretreatment with different concentrations of curcumin as indicated. RNA was extracted and the inflammatory response marker, IL-8 mRNA expression and ER stress marker, BiP mRNA expression level measured by qRT-PCR. Open bars represent negative controls. Thaps: Thapsigargin, Data are expressed as mean ± SEM. *P < 0.05 by ANOVA.

• 

  Fig. 4 Curcumin treatment displayed no change of the epithelial junction in human intestinal epithelial cells after intoxication. (A) Polarized human intestinal epithelia cell line T84 cells were treated with 40 nM wild-type Cholera Toxin apically for 24 hours, respectively, following 24 hour pretreatment with 1 uM curcumin. The cells were fixed and stained with anti-ZO-1 antibody (green color for tight junction), anti-Phalloidin antibody (red color for actin skeleton), and DRAQ5 (blue color for nucleus). There was no change of the tight junction by curcumin. Arrows indicate the epithelial junction. (B) Proposed role of curcumin in anti-inflammatory response. wt CT: wild-type cholera toxins.

Reference

1. Ron D, Hubbard SR. How IRE1 reacts to ER stress. Cell. 2008; 132:24–26.

2. Cho JA, Lee AH, Platzer B, Cross BC, Gardner BM, De Luca H, Luong P, Harding HP, Glimcher LH, Walter P, Fiebiger E, Ron D, Kagan JC, Lencer WI. The unfolded protein response element IRE1alpha senses bacterial proteins invading the ER to activate RIG-I and innate immune signaling. Cell Host Microbe. 2013; 13:558–569.

3. Ji JL, Huang XF, Zhu HL. Curcumin and its formulations: potential anti-cancer agents. Anticancer Agents Med Chem. 2012; 12:210–218.

4. Kubota M, Shimizu M, Sakai H, Yasuda Y, Terakura D, Baba A, Ohno T, Tsurumi H, Tanaka T, Moriwaki H. Preventive effects of curcumin on the development of azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db obese mice. Nutr Cancer. 2012; 64:72–79.

5. Zeng Z, Zhan L, Liao H, Chen L, Lv X. Curcumin improves TNBS-induced colitis in rats by inhibiting IL-27 expression via the TLR4/NF-kappaB signaling pathway. Planta Med. 2013; 79:102–109.

6. Song WB, Wang YY, Meng FS, Zhang QH, Zeng JY, Xiao LP, Yu XP, Peng DD, Su L, Xiao B, Zhang ZS. Curcumin protects intestinal mucosal barrier function of rat enteritis via activation of MKP-1 and attenuation of p38 and NF-kappaB activation. PLoS One. 2010; 5:e12969.

7. Jian YT, Mai GF, Wang JD, Zhang YL, Luo RC, Fang YX. Preventive and therapeutic effects of NF-kappaB inhibitor curcumin in rats colitis induced by trinitrobenzene sulfonic acid. World J Gastroenterol. 2005; 11:1747–1752.

8. Zhang F, Altorki NK, Mestre JR, Subbaramaiah K, Dannenberg AJ. Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells. Carcinogenesis. 1999; 20:445–451.

9. Zhang M, Deng C, Zheng J, Xia J, Sheng D. Curcumin inhibits trinitrobenzene sulphonic acid-induced colitis in rats by activation of peroxisome proliferator-activated receptor gamma. Int Immunopharmacol. 2006; 6:1233–1242.

10. Bounaama A, Djerdjouri B, Laroche-Clary A, Le Morvan V, Robert J. Short curcumin treatment modulates oxidative stress, arginase activity, aberrant crypt foci, and TGF-beta1 and HES-1 transcripts in 1,2-dimethylhydrazine-colon carcinogenesis in mice. Toxicology. 2012; 302:308–317.

11. Epstein J, Docena G, MacDonald TT, Sanderson IR. Curcumin suppresses p38 mitogen-activated protein kinase activation, reduces IL-1beta and matrix metalloproteinase-3 and enhances IL-10 in the mucosa of children and adults with inflammatory bowel disease. Br J Nutr. 2010; 103:824–832.

12. Moon DO, Jin CY, Lee JD, Choi YH, Ahn SC, Lee CM, Jeong SC, Park YM, Kim GY. Curcumin decreases binding of Shiga-like toxin-1B on human intestinal epithelial cell line HT29 stimulated with TNF-alpha and IL-1beta: suppression of p38, JNK and NF-kappaB p65 as potential targets. Biol Pharm Bull. 2006; 29:1470–1475.

13. Lencer WI, Delp C, Neutra MR, Madara JL. Mechanism of cholera toxin action on a polarized human intestinal epithelial cell line: role of vesicular traffic. J Cell Biol. 1992; 117:1197–1209.

14. Glimcher LH, Lindvall O, Aguirre V, Topalian SL, Musunuru K, Fauci AS. Translating research into therapies. Cell. 2012; 148:1077–1078.

15. Garrett WS, Gordon JI, Glimcher LH. Homeostasis and inflammation in the intestine. Cell. 2010; 140:859–870.

16. Heazlewood CK, Cook MC, Eri R, Price GR, Tauro SB, Taupin D, Thornton DJ, Png CW, Crockford TL, Cornall RJ, Adams R, Kato M, Nelms KA, Hong NA, Florin TH, Goodnow CC, McGuckin MA. Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis. PLoS Med. 2008; 5:e54.

17. DiDonato JA, Mercurio F, Karin M. NF-kappaB and the link between inflammation and cancer. Immunol Rev. 2012; 246:379–400.

18. Sun B, Karin M. Obesity, inflammation, and liver cancer. J Hepatol. 2012; 56:704–713.

19. Karin M. Tracking the road from inflammation to cancer: the critical role of IkappaB kinase (IKK). Harvey Lect. 2006-2007; 102:133–151.

20. Karin M. The IkappaB kinase-a bridge between inflammation and cancer. Cell Res. 2008; 18:334–342.